Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 2Phase 3 2Phase 1/2 2

Status

Recruiting 3Completed 3Withdrawn 2Unknown 2Terminated 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 1Other hematologic neoplasm 1Dermatologic 1

Conditions

Sarcoma 1Melanoma 1Hematologic Neoplasms 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Solutions × Clear all
NCT05952804 2026-04-21

IVIG for Infection Prevention After CAR-T-Cell Therapy

Fred Hutchinson Cancer Center

Phase 2 Recruiting
150 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT07230613 2026-02-11

NEOREM-NEO-1

UNICANCER

Phase 2 Recruiting
50 enrolled
Dermatologic

Melanoma

NCT03886311 2025-02-24

TNT

Sarcoma Oncology Research Center, LLC

Phase 2 Recruiting
200 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡